Stifel Financial Corp Raises Position in Koninklijke Philips (NYSE:PHG)

Stifel Financial Corp increased its holdings in Koninklijke Philips (NYSE:PHG - Free Report) by 16.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 195,222 shares of the technology company's stock after acquiring an additional 27,536 shares during the quarter. Stifel Financial Corp's holdings in Koninklijke Philips were worth $6,388,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of PHG. FMR LLC grew its stake in shares of Koninklijke Philips by 0.6% in the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company's stock valued at $200,859,000 after purchasing an additional 35,935 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Koninklijke Philips by 27.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company's stock valued at $101,718,000 after buying an additional 864,951 shares during the last quarter. Millennium Management LLC increased its stake in Koninklijke Philips by 822.0% in the 2nd quarter. Millennium Management LLC now owns 1,120,521 shares of the technology company's stock valued at $28,237,000 after buying an additional 998,995 shares during the period. Bank of Montreal Can increased its stake in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company's stock valued at $32,157,000 after buying an additional 949,278 shares during the period. Finally, Natixis Advisors LLC raised its position in Koninklijke Philips by 5.2% during the 2nd quarter. Natixis Advisors LLC now owns 930,085 shares of the technology company's stock worth $23,438,000 after buying an additional 46,268 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on PHG. Jefferies Financial Group upgraded shares of Koninklijke Philips from an "underperform" rating to a "hold" rating in a research note on Tuesday, October 29th. StockNews.com cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Thursday, November 14th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold".

Koninklijke Philips Price Performance

Shares of NYSE PHG traded up $0.16 during midday trading on Friday, hitting $25.79. The company had a trading volume of 508,548 shares, compared to its average volume of 944,764. The firm has a market capitalization of $24.24 billion, a price-to-earnings ratio of -61.40, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76. Koninklijke Philips has a twelve month low of $19.55 and a twelve month high of $32.91. The business has a 50-day simple moving average of $28.13 and a two-hundred day simple moving average of $28.20. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.